Molecular markers for osteoarthritis: the road ahead
Authors:
- Jeroen DeGrootJDJeroen DeGroot
- Ruud A. BankRBRuud A. Bank
- Ilja TchetverikovITIlja Tchetverikov
- Nicole VerzijlNVNicole Verzijl
- Johan M. TeKoppeleJTJohan M. TeKoppele
- 1 September 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 14 (5) , 585-589
Abstract
Osteoarthritis is a disabling joint disease that is characterized by the progressive destruction of articular cartilage. Diagnosis is based on clinical symptoms in combination with radiography, which is relatively insensitive and provides only an indication of accumulated damage. Alternative methods, such as molecular markers, are therefore needed that can quantitatively, reliably, and sensitively detect osteoarthritic changes in the joints at an early stage of the disease. Such molecular markers are essential for diagnosis, prognosis, and monitoring of disease progression and efficacy of therapy that is targeted at joint destruction. In addition, these markers are important for the development of new disease-modifying therapies. This concise review discusses the developments over the past 2 years in the field of molecular markers for osteoarthritis.Keywords
This publication has 32 references indexed in Scilit:
- Collagen type II C-telopeptide fragments as an index of cartilage degradationBone, 2001
- Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damageAnnals of the Rheumatic Diseases, 2001
- The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget’s disease of boneBone, 2001
- An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-pointsOsteoarthritis and Cartilage, 2001
- Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISAJournal of Immunological Methods, 2001
- The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradationArthritis & Rheumatism, 2000
- An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baselineOsteoarthritis and Cartilage, 2000
- Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenaseArthritis & Rheumatism, 2000
- Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibodyMatrix Biology, 1999
- Evidence for altered synthesis of type II collagen in patients with osteoarthritis.Journal of Clinical Investigation, 1998